Jesus Martos-Loarce

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Journal: European journal of internal medicine

Published: April 01, 2026

Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry.

Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry.

Journal: Seminars in arthritis and rheumatism

Published: March 07, 2026

Diagnostic performance of lung ultrasound for systemic sclerosis-associated interstitial lung disease: an international cross-sectional study from two tertiary care centers.

Diagnostic performance of lung ultrasound for systemic sclerosis-associated interstitial lung disease: an international cross-sectional study from two tertiary care centers.

Journal: Clinical rheumatology

Published: January 23, 2026

Validation of the SER/SEPAR criteria for the screening of interstitial lung disease in a large cohort of patients with rheumatoid arthritis.

Validation of the SER/SEPAR criteria for the screening of interstitial lung disease in a large cohort of patients with rheumatoid arthritis.

Journal: Reumatologia clinica

Published: September 04, 2025

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients.

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients.

Journal: Rheumatology (Oxford, England)

Published: August 26, 2025

Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.

Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.

Journal: Rheumatology (Oxford, England)

Published: January 22, 2025

Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients.

Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients.

Journal: Seminars in arthritis and rheumatism

Published: January 07, 2025

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.

Journal: Arthritis research & therapy

Published: August 19, 2024

Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.

Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 07, 2024

Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.

Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.

Journal: Seminars in arthritis and rheumatism

Published: March 04, 2024

Efficacy and safety of intravenous immunoglobulin therapy in systemic sclerosis: a systematic review.

Efficacy and safety of intravenous immunoglobulin therapy in systemic sclerosis: a systematic review.

Journal: Rheumatology international

Published: February 17, 2024

Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity.

Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity.

Journal: Rheumatology international

Published: October 12, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026